Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2003, p. 2590-2597, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2590-2597.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Potent Inhibitors of Plasmodium Phospholipid Metabolism with a Broad Spectrum of In Vitro Antimalarial Activities
Marie L. Ancelin,1 Michèle Calas,2 Valérie Vidal-Sailhan,2 Serge Herbuté,1 Pascal Ringwald,3 and Henri J. Vial1*
UMR 5539,1
LAPP, UMR 5810, CNRS, Université Montpellier II, 34095 Montpellier Cedex 5, France,2
Laboratoire de Recherche sur le Paludisme, OCEAC, IRD, Yaoundé, Cameroon3
Received 14 November 2002/
Returned for modification 12 March 2003/
Accepted 10 May 2003
We characterized the potent in vitro antimalarial activity and biologic assessment of 13 phospholipid polar head analogs on a comparative basis. There was a positive relationship between the abilities of the drugs to inhibit parasite growth in culture and their abilities to specifically inhibit phosphatidylcholine biosynthesis of Plasmodium falciparum-infected erythrocytes. Maximal activity of G25 was observed for the trophozoite stage of the 48-h erythrocytic cycle (50% inhibitory concentration, 0.75 nM), whereas the schizont and ring stages were 12- and 213-fold less susceptible. The compounds exerted a rapid nonreversible cytotoxic effect, with complete clearance of parasitemia after 5 h of contact with the mature stages. The compounds were highly specific against P. falciparum, with much lower toxicity against three other mammalian cell lines, and the in vitro therapeutic indices ranged from 300 to 2,500,000. Finally, the monoquaternary ammonium E10 and two bis-ammonium salts, G5 and G25, were similarly active against multiresistant strains and fresh isolates of P. falciparum. This impressive selective in vitro toxicity against P. falciparum strongly highlights the clinical potential of these quaternary ammonium salts for malarial chemotherapy.
* Corresponding author. Mailing address: UMR 5539, CNRS, Université Montpellier II, CP 107, Place Bataillon, 34095 Montpellier Cedex 5, France. Phone: 33 0 4 6714 3745. Fax: 33 0 4 6714 4286. E-mail:
vial{at}univ-montp2.fr.
Antimicrobial Agents and Chemotherapy, August 2003, p. 2590-2597, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2590-2597.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Benoit-Vical, F., Lelievre, J., Berry, A., Deymier, C., Dechy-Cabaret, O., Cazelles, J., Loup, C., Robert, A., Magnaval, J.-F., Meunier, B.
(2007). Trioxaquines Are New Antimalarial Agents Active on All Erythrocytic Forms, Including Gametocytes. Antimicrob. Agents Chemother.
51: 1463-1472
[Abstract]
[Full Text]
-
Choubey, V., Maity, P., Guha, M., Kumar, S., Srivastava, K., Puri, S. K., Bandyopadhyay, U.
(2007). Inhibition of Plasmodium falciparum Choline Kinase by Hexadecyltrimethylammonium Bromide: a Possible Antimalarial Mechanism. Antimicrob. Agents Chemother.
51: 696-706
[Abstract]
[Full Text]
-
Richier, E., Biagini, G. A., Wein, S., Boudou, F., Bray, P. G., Ward, S. A., Precigout, E., Calas, M., Dubremetz, J.-F., Vial, H. J.
(2006). Potent Antihematozoan Activity of Novel Bisthiazolium Drug T16: Evidence for Inhibition of Phosphatidylcholine Metabolism in Erythrocytes Infected with Babesia and Plasmodium spp.. Antimicrob. Agents Chemother.
50: 3381-3388
[Abstract]
[Full Text]
-
Witola, W. H., Pessi, G., El Bissati, K., Reynolds, J. M., Mamoun, C. B.
(2006). Localization of the Phosphoethanolamine Methyltransferase of the Human Malaria Parasite Plasmodium falciparum to the Golgi Apparatus. J. Biol. Chem.
281: 21305-21311
[Abstract]
[Full Text]
-
Nicolas, O., Margout, D., Taudon, N., Wein, S., Calas, M., Vial, H. J., Bressolle, F. M. M.
(2005). Pharmacological Properties of a New Antimalarial Bisthiazolium Salt, T3, and a Corresponding Prodrug, TE3. Antimicrob. Agents Chemother.
49: 3631-3639
[Abstract]
[Full Text]
-
Nicolas, O., Farenc, C., Calas, M., Vial, H. J., Bressolle, F.
(2005). Quantification of Antimalarial Bisthiazolium Compounds and Their Neutral Bioprecursors in Plasma by Liquid Chromatography-Electrospray Mass Spectrometry. Clin. Chem.
51: 593-602
[Abstract]
[Full Text]
-
Biagini, G. A., Pasini, E. M., Hughes, R., De Koning, H. P., Vial, H. J., O'Neill, P. M., Ward, S. A., Bray, P. G.
(2004). Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. Blood
104: 3372-3377
[Abstract]
[Full Text]
-
Vial, H. J., Wein, S., Farenc, C., Kocken, C., Nicolas, O., Ancelin, M. L., Bressolle, F., Thomas, A., Calas, M.
(2004). Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc. Natl. Acad. Sci. USA
101: 15458-15463
[Abstract]
[Full Text]
-
Roggero, R., Zufferey, R., Minca, M., Richier, E., Calas, M., Vial, H., Ben Mamoun, C.
(2004). Unraveling the Mode of Action of the Antimalarial Choline Analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae. Antimicrob. Agents Chemother.
48: 2816-2824
[Abstract]
[Full Text]